Evidence map›Paper›PMID 41221116›Full record

ArticleChemical science2026

Catalytic asymmetric construction of remote P or other heteroatom (Si/S) stereogenic axially chiral scaffolds.

Wenqi Liu, Zhijie Ling, Yang-Zi Liu, Wei-Ping Deng

Abstract read
In one paragraph

Article in Chemical science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wenqi LiuKey Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, Zhejiang Normal University 688 Yingbin Road Jinhua Zhejiang 321004 China liuyangzi@zjun.edu.cn dengwp827@zjnu.edu.cn.
Zhijie LingKey Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, Zhejiang Normal University 688 Yingbin Road Jinhua Zhejiang 321004 China liuyangzi@zjun.edu.cn dengwp827@zjnu.edu.cn.
Yang-Zi LiuKey Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, Zhejiang Normal University 688 Yingbin Road Jinhua Zhejiang 321004 China liuyangzi@zjun.edu.cn dengwp827@zjnu.edu.cn.ORCID https://orcid.org/0000-0001-6702-4507
Wei-Ping DengKey Laboratory of the Ministry of Education for Advanced Catalysis Materials, College of Chemistry and Materials Science, Zhejiang Normal University 688 Yingbin Road Jinhua Zhejiang 321004 China liuyangzi@zjun.edu.cn dengwp827@zjnu.edu.cn.ORCID https://orcid.org/0000-0002-4232-1318

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Axial chirality represents a fundamental element of stereochemistry and is a defining structural feature in many chiral compounds. Although the axial chirality of atropisomers, allenes and spiranes has been extensively studied, the chemistry of alkylidenecycloalkanes and their analogues-especially those possessing P-, S- or Si-based axial chirality-remains underdeveloped. Here we report a chiral phosphoric acid-catalyzed oxime condensation that enables the construction of remote heteroatom (P/S/Si)-stereogenic axially chiral scaffolds. The reaction accommodates a broad range of functional groups, delivering optically active axially chiral 9-heteroanthrone-based oxime ethers in good to excellent enantioselectivities (up to 98 : 2 er). We also describe a modular synthesis of dibenzoazaphosphepinones and demonstrate their application as chiral monodentate phosphine ligands in asymmetric catalysis.

Identifiers

PMID41221116
PMCPMC12599203

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.